Case Report - Journal of Clinical and Experimental Toxicology (2021) Volume 4, Issue 3
Life threatening hepatotoxicity induced by Nilotinib.
Adverse events remain an obstacle to follow successful responding treatment. Solutions and manuscripts for monitoring drugs are essential, especially when it’s about a dangerous untoward occurrence. We report the case of 57 year-old woman with chronic myeloid leukemia who developed a rare life threatening hepatotoxicity (grade 4) secondary to Nilotinib? and how we ruled this. A monitoring of the disease as well as the treatment is mandatory.Author(s): Latifa Khelifa